-$0.03 Earnings Per Share Expected for Surgery Partners, Inc. (NASDAQ:SGRY) This Quarter

Wall Street analysts predict that Surgery Partners, Inc. (NASDAQ:SGRYGet Rating) will announce ($0.03) earnings per share for the current fiscal quarter, Zacks Investment Research reports. Five analysts have provided estimates for Surgery Partners’ earnings, with estimates ranging from ($0.07) to ($0.01). The company is expected to announce its next earnings report on Monday, January 1st.

According to Zacks, analysts expect that Surgery Partners will report full year earnings of $0.29 per share for the current fiscal year, with EPS estimates ranging from $0.05 to $0.48. For the next financial year, analysts anticipate that the business will post earnings of $0.66 per share, with EPS estimates ranging from $0.38 to $0.83. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that that provide coverage for Surgery Partners.

Surgery Partners (NASDAQ:SGRYGet Rating) last released its quarterly earnings results on Tuesday, May 3rd. The company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.02. Surgery Partners had a negative net margin of 1.63% and a negative return on equity of 0.46%. During the same quarter last year, the firm earned ($0.40) EPS.

A number of brokerages have commented on SGRY. Citigroup lifted their target price on shares of Surgery Partners from $61.00 to $64.00 in a research note on Wednesday, May 4th. SVB Leerink lifted their price objective on shares of Surgery Partners from $63.00 to $65.00 and gave the company an “outperform” rating in a report on Wednesday, March 2nd. Zacks Investment Research cut shares of Surgery Partners from a “hold” rating to a “sell” rating in a report on Tuesday, May 10th. JPMorgan Chase & Co. lifted their price target on shares of Surgery Partners from $50.00 to $55.00 and gave the stock a “neutral” rating in a research note on Wednesday, March 2nd. Finally, Benchmark lifted their price target on shares of Surgery Partners from $65.00 to $72.00 in a research note on Wednesday, May 4th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $60.11.

Shares of NASDAQ:SGRY traded up $0.78 during midday trading on Wednesday, hitting $39.83. The company’s stock had a trading volume of 523,977 shares, compared to its average volume of 445,316. The business’s 50 day simple moving average is $51.28 and its 200 day simple moving average is $49.69. The company has a debt-to-equity ratio of 1.50, a quick ratio of 1.61 and a current ratio of 1.73. The company has a market cap of $3.58 billion, a P/E ratio of -75.15, a price-to-earnings-growth ratio of 10.78 and a beta of 2.76. Surgery Partners has a 12-month low of $36.96 and a 12-month high of $69.58.

In other Surgery Partners news, CFO David T. Doherty sold 3,678 shares of Surgery Partners stock in a transaction on Tuesday, March 15th. The shares were sold at an average price of $49.29, for a total value of $181,288.62. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider George Goodwin sold 25,525 shares of Surgery Partners stock in a transaction on Thursday, April 21st. The stock was sold at an average price of $62.58, for a total transaction of $1,597,354.50. Following the completion of the transaction, the insider now directly owns 57,990 shares of the company’s stock, valued at approximately $3,629,014.20. The disclosure for this sale can be found here. Insiders sold 116,220 shares of company stock worth $6,300,372 in the last 90 days. 3.30% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently modified their holdings of SGRY. Signaturefd LLC bought a new stake in Surgery Partners in the fourth quarter worth about $63,000. PNC Financial Services Group Inc. grew its stake in Surgery Partners by 34.7% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,195 shares of the company’s stock valued at $66,000 after acquiring an additional 308 shares in the last quarter. Nisa Investment Advisors LLC grew its stake in Surgery Partners by 444.4% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,960 shares of the company’s stock valued at $84,000 after acquiring an additional 1,600 shares in the last quarter. Allspring Global Investments Holdings LLC purchased a new position in Surgery Partners during the 4th quarter valued at about $92,000. Finally, Balyasny Asset Management LLC bought a new stake in shares of Surgery Partners in the 3rd quarter valued at approximately $203,000.

Surgery Partners Company Profile (Get Rating)

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Further Reading

Get a free copy of the Zacks research report on Surgery Partners (SGRY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.